12.29 USD
▲+0.09+3.45%
盘后 11.88 0.00%
2026-08-03
市值
$1.14B
市盈率
—
EPS
-1.49
股息率
—
52 周区间
6.62 – 15.35
成交量
573.14K
Beta
1.21
目标价
30.00
52W 低 6.6252W 高 15.35
价格走势
公司简介
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xerostomia, as well as for Sjogren’s syndrome; AAV-GAD in Phase 2 trial for Parkinson’s disease; AAV-RPE65 in Phase 2 trial for RPE65-associated retinal ...